NCT04494451View on ClinicalTrials.gov

Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Liver Cirrhosis
Interventions
DRUG

Vit C

vitamin C (25 mg/kg or max. 1.5 gram every 6 hourly) for maximum 5 day

DRUG

Standard medical Treatment

iv antibiotics alone

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT04494451 - Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections. | Biotech Hunter | Biotech Hunter